CUHK Neurology

[CUHK Neurology @CUHKneurology]

@IpBonaventure is presenting #GALLOP2 at #ESOC2026 — a multicenter randomized trial evaluating semaglutide in acute large vessel occlusion stroke treated with EVT.
The study highlights a potential new neuroprotective strategy for severe stroke.

#Stroke #Neurology #CUMedicine

[CUHK Medicine @CUHKMedicine]

Breakthrough: @CUHKMedicine & @CUHK_GCNI show the weight loss drug GLP-1RA can counteract key hallmarks of ageing across multiple organs—including the brain & the heart—and may aid stroke recovery! Semaglutide led to 20% more patients achieving better neuro recovery after severe stroke (without IV thrombolysis) vs. standard therapy. Findings published in Cell Metabolism & Nature Communications, learn more on @cellmetabolism and @naturecommunication.

[NeuroNews @NN_publishing]

Semaglutide appears to be an effective adjunct to thrombectomy in LVO stroke patients not receiving thrombolytics, demonstrating improved functional outcomes as well as comparable mortality and sICH rates vs standard care in the GALLOP-2 trial
#ESOC2026 @ESOstroke @IpBonaventure

[CUHK Medicine @CUHKMedicine]

【Medicine Across Generations: Neuroscience Heritage and Innovations】
Knowledge, values and mentorship have been passed down across generations of scientists, ensuring that each generation leaves something stronger for the next.
Explore more on Med Tolo, the CU Medicine alumni e-newsletter. https://t.co/O3nnizJvFB

[CUHK Neurology @CUHKneurology]

#CUHKNeurology wishes you and your family a healthy, prosperous and joyful Year of the Horse!🧧
@CUHKneurology

[CUHK Neurology @CUHKneurology]

Our assistant professor @IpBonaventure presented research on the Clinical Effectiveness of an Integrated Chinese–Western Medicine Program in Stroke Rehabilitation at #ISC2026. Read the abstract here: https://t.co/WZZsZ4DBh6

[CUHK Medicine @CUHKMedicine]

We are delighted to share that Professor Carol Cheung (@CarolCheung1023) , Dr Owen Ko (@shibadaddo) and Professor Vincent Mok (@VincentCTMok) from @CUHKMedicine have recently received the #Best Use of AI Award and the #Smart People (Smart Ageing) Silver Award of #2025 Hong Kong ICT Awards for i-Cog Brain Health, the world’s first #AI-powered #retinal imaging analytic algorithm for screening Alzheimer's dementia and evaluating brain health within a few minutes.

[The Chinese University of Hong Kong - CUHK @CUHKofficial]

A breakthrough study by the School of Life Sciences and the Gerald Choa Neuroscience Institute at CUHK has revealed for the first time that hormonal imbalance during women’s perimenopausal period affects brain cell energy metabolism, significantly increasing the risk of Alzheimer’s disease (AD).

During perimenopause, fluctuations in the female hormones oestradiol (E2) and progesterone (P4) often lead to oestrogen dominance, where E2 remains high while P4 is insufficient. This not only weakens the energy production efficiency of neurons but also exacerbates brain cell energy imbalance. This can trigger toxic reactions from neuronal over-excitation, leading to the collapse of energy metabolism and apoptosis, or cell death, ultimately increasing the risk of pathological features associated with AD. This discovery offers a new direction for the early prevention of neurodegeneration in women.

Details: https://t.co/Yn44UTzwy0

#CUHK #thechineseuniversityofhongkong

[MDS @movedisorder]

World Movement Disorders Day is THIS SATURDAY — November 29!
Share what moves you, or raise important awareness with our toolkit: https://t.co/YtrRmDGJ8d

[CUHK Medicine @CUHKMedicine]

.@CUHKMedicine & @CUHKengineering, to echo with #WorldBrainDay, has jointly developed a novel sub-millimetre Magnetically Actuated Soft Rotatable-tipped Microcatheter for more precise, safer and faster treatment of acute ischemic strokes.

▶️https://t.co/IxvVrhYOZ8
📖@ScienceAdvances: https://t.co/QjImfxPUNk

[CUHK Medicine @CUHKMedicine]

.@CUHKMedicine & PWH pioneer low-field #MRI technology to launch the Emergency Stroke Unit (#ESU), HK’s #1st one-stop acute #stroke management model, which has reduced the door-to-needle time to an average of 20 minutes. https://t.co/krtBFBTtks

[CUHK Medicine @CUHKMedicine]

Prof @VincentCTMok from @CUHKMedicine was awarded the 2024 Advance Global Australian Award, organised by @Advance in the Education, Science, and Research category for his contributions and achievements in the field of #dementia and #cerebrovascular diseases. Congratulations! 🎉

[CUHK Medicine @CUHKMedicine]

.@CUHKMedicine & PWH pioneer low-field #MRI technology to launch the Emergency Stroke Unit (ESU), HK’s #first one-stop acute #stroke management model, which has reduced the door-to-needle time to an average of 20 minutes. https://t.co/IoQ4MdSPgF

[CUHK Medicine @CUHKMedicine]

.@CUHKneurology conducted the world’s first study comparing intracerebral hemorrhage treatments for Chinese patients with #AtrialFibrillation, and found prothrombin complex concentrate did not significantly improve recovery outcomes compared to conservative treatment. https://t.co/xTr03GRwQn

📖@JAMANetworkOpen : https://t.co/E3CxzNO6Af

[CUHK Neurology @CUHKneurology]

Congratulations to Dr. Lina Zheng and Dr. Xinyi Leng on being the recipient of the #EuropeanStrokeJournal Virtual Abstract Award! #ESOC2024

[CUHK Medicine @CUHKMedicine]

Research team from @CUHKMedicine and @CUHKengineering develops magnetic tPA-anchored nanorobots (tPA-nbots) to treat ischemic #stroke. It exhibits a #thrombolysis rate 5-20 times faster than traditional treatment and capabilities in recanalising distal and smaller branches. https://t.co/raPr3yfDpL

📖@ScienceMagazine: https://t.co/A0Fse4BYsi & https://t.co/Yoaq00wAQU

[CUHK Medicine @CUHKMedicine]

Congratulations to Dr Owen KO (@shibadaddo) on receiving the Outstanding Alumni Award from @londonballfoundation, recognising his contributions and commitment to community service and nurturing talent. #LondonBall2024 #OutstandingAlumni